Globally, the market of bisurgery was priced at US$ 13,887.5 million in the year 2021 and is estimated to the extent of US$ 22,212.9 million by the end of the 2028 at a CAGR of 6.9% from 2022 to 2028. The market of biosurgery across the globe is witnessing robust growth owing to the increase in incidence of CVD (cardiovascular) diseases and increasing elderly/geriatric population globally. Furthermore, rise in use of improved tools and devices of surgery and the increasing health consciousness and growth of healthcare framework is anticipated to fuel the market growth. Though, issues like lack of cognizance amongst people in relation to biosurgery and high surgery cost are anticipated to hinder the growth of the market.
Request Here For The Sample Copy Of The Report @ https://www.coherentmarketinsights.com/insight/request-sample/5457
Global Biosurgery Market: Regional Insights
On the basis of geography, the market of biosurgery worldwide is divided into Asia Pacific, Europe, North America and Latin America, and Middle East & Africa.
Based on the region, North America is anticipated to have the major share of the market in the predicted period due to the increase in occurrence of prolonged diseases and associated surgeries and increasing elderly population in this region. For example, with the rise in occurrence of prolonged diseases, like heart disease, the figures of the associated surgeries also rose with an increased pace. As per CDC (Center for Disease Control Prevention), the main cause of death in the United States among men, women, people in the racial and the ethnic groups of people is heart attack. In the United States, every 34 seconds, a person dies due to CVD.
Europe and Asia Pacific are anticipated to experience strong growth in the market of biosurgery across the world owing to the rise in the problem of cardiovascular disease and increasing elderly population in the region. For example, age of adults ranging from 65 and above are more prone to suffer from cardiovascular diseases (CVD) in comparison to young people. The population of Asia Pacific is noticing faster aging population than other regions of the world. As per United Nations Economic and Social Commission for Asia and the Pacific in July 2022, the total number of people of age 60years and more is 630 Mn, accounting for about 60% of the old people in the world. By the end of the year 2050, the number is estimated to raise upto 1.3 billion.
Global Biosurgery Market Drivers
High occurrence of cardiovascular diseases (CVDs) to expand the growth of the market.
The main factors anticipated to enhance the market growth of the biosurgery worldwide in the predicted period is the increase in occurrence of CVD’s across the world. A very high problem of cardiovascular diseases results in an augmented figure of surgical processes and it is anticipated to fuel the growth of the market. As per WHO (World Health Organization), cardiovascular diseases are the main factors leading to death worldwide, about 17.9 Mn lives every year. This is anticipated to push the market growth.
Increasing elderly or the geriatric population to reinforce the growth of the market.
The other factor that is pushing the market growth of the biosurgery worldwide is the increasing aging population worldwide. For example, aging causes change of blood vessels and heart which increases the possibility among them suffering from CVD’s. People with age ranging from 5 and above are more susceptible to the cardiovascular diseases as compared to young people. As per UN DESA’s Population Division, every 1 in 6 people across the world will age above age above 65 by the end of the year 2050, rose from 1 in every 11 in the year 2019. In many areas, population of people aging 65 will get double by the end of the year 2050, and the life expectancy of the world below 5 years will rise by 19 years.
Global Biosurgery Market Opportunities
Rising usage of improved tools and devices of surgeries is anticipated to provide substantial opportunities of growth for the companies in the market of biosurgery worldwide. For example, with the rise in surgical process figures worldwide, the need for improved tools and devices for surgeries is also rising or has been raised at a very fast speed. Baxter International in February 2020 got the clearance from US FDA to launch the product of biosurgery (Peri strips dry integrated with VERITAS collagen matrix). It is extensively applied in reducing the bleeding rate during conducting many bariatric surgeries and other surgical methods.
Increasing health consciousness and the growth of the healthcare framework is anticipated to offer substantial opportunities of growth for the companies in the market of biosurgery worldwide. For example, increase in consciousness in regard to biosurgery benefits as compared to conventional surgical procedures and the increase in cognizance in terms of improved surgical methods are the main causes nurturing the market growth. Therefore, with the rise in consciousness and growth in healthcare framework, the figure of bio-surgeries is rising too with an increased pace across the world. This is anticipated to help in the market growth of the bisurgery worldwide in the predicted period.
We Offer Customized Report, Click @ https://www.coherentmarketinsights.com/insight/request-customization/5457
Global Biosurgery Market Trends
Rise in number of surgical processes is a recent fashion
The rise in problem of CVD’s (cardiovascular diseases) across the world is resulting in a rise in the figure of surgical processes. This has raised the need for improved tools and devices for surgery, and therefore, companies in the market are emphasizing on introducing new products owing to the increase in the problem of CVD’s added with the rise in aging population. This is anticipated to push the market growth of biosurgery worldwide.
Rise in R&D (research and development) is another fashion
The market at present is transforming the schedule of treating for many diseases and the market is developing drastically at the moment. Several R&D activities are taking place at present, which is anticipated to offer incredible opportunities of growth for the companies in the market. This fashion is also anticipated to last in the predicted period, pushing the market growth of the biosurgery worldwide.
Global Biosurgery Market Restraints
Lack of consumer consciousness to hamper the market growth.
The main factor anticipated to hinder the market growth of the biosurgery worldwide is the lack of consciousness in regard to biosurgery benefits in the emerging countries. The use of biosurgery or the liking for biosurgery is low in the emerging countries owing to the lack of cognizance amongst people about the biosurgery benefits. Though, increase in consciousness about biosurgery benefits as compared to conventional surgical processes and increase in consciousness in terms of improved surgical processes is anticipated to enhance the market growth.
High surgery cost to hinder the market growth
The other factor that is hindering the market growth of the biosurgery worldwide is the high improved surgical processes’ cost and high biosurgery products cost. Normally, the bio-surgeries experience high costs due to the before and after surgical fees. Furthermore, the high cost of procedures and other extra expenditures on post-surgery garments, medical tests, and medical tests expenses, and medications are the main causes that are anticipated to hamper the market growth.
Global Biosurgery Market Segmentation
The market of biosurgery is divided into Treatment Type, Disease Type and Geopgraphy.
On the basis of type of treatment, the market of biosurgery worldwide is divided into Hemostatic Agents, Surgical Sealants/Adhesives, Adhesion Barriers, Bone-graft Substitutes, Soft-tissue Attachments, and Staple Line Reinforcement. Among which, the segment of Hemostatic Agents is anticipated to control the market of biosurgery in the predicted period and this is credited to the rise in figure of surgical processes. Hemostatic agents dominate the bleeding caused externally by increasing the natural process of clotting and therefore are extensively helpful in controlling bleeding.
Bone-Graft Substitutes Segment is also anticipated to experience substantial opportunities of growth in the coming future and this is due to the rise in use of bone-graft substitutes. They are needed in oncological surgeries, prosthetic reconstruction, traumatology, and spinal surgeries.
On the basis of type of disease, the market is divided into Orthopedic Surgery, Cardiovascular Surgery, General Surgery, Gynecological Surgery, Neurological Surgery and Other Applications. Amongst which, the segment of orthopedic surgery is anticipated to control the market in the predicted period and this is credited to the rise in number of orthopedic surgeries.
Cardiovascular Surgery Segment is also anticipated to experience substantial development in the coming future and this is due to the increase in the figure of cardiovascular surgeries and increasing aging population.
Global Biosurgery Market: Key Developments
Baxter International Inc. in May 2020 obtained consent from US FDA (Ubited States Food and Drug Administration) for Altapore Shape Bioactive Bone Graft which is the new addition to Baxter’s next-gen bone graft substitute product line.
BD in June 2020 finished the acquisition of Straub Medical Ag which is a privately-held company that makes and sells medical atherectomy and thrombectomy devices.
Integra LifeSciences Holdings in September 2019 acquired Rebound Therapeutics which is the developer of single-use medical devices that allows minimally-invasive admission by means of optics and illumination for diagnostics, visualization and therapeutic applications in neurosurgery.
Baxter International in April 2019 got its Floseal Hemostatic matrix for using in surgical methods. The improved generation Floseal has 20% less ingredients and preparation steps making it easier and faster for using it in the operating room.
Direct Buy This Premium Research Report, Click Here @ https://www.coherentmarketinsights.com/insight/buy-now/5457
Global Biosurgery Market: Key Companies Insights
Globally, the market of biosurgery is very much competitive in nature. This is credited to the rise in need for improved tools and devices for surgery, consequently, companies in the market are emphasizing on the new product’s introduction in the market.
Some of the main companies operating in the market of biosurgery worldwide includes Betatech Medical, Hemostasis LLC, CryoLife Inc., CSL Limited, Medtronic PLC, Johnson & Johnson, B.Braun Melsungen AG, Baxter International Inc., Integra Lifesciences Holdings Corporation, and Becton, Dickinson and Company (CR Bard), among others.
Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Biosurgery Market Size Analysis from 2023 to 2030
11.6 COVID-19 Outbreak: Biosurgery Industry Impact
Chapter 2 Global Biosurgery Competition by Types, Applications, and Top Regions and Countries
2.1 Global Biosurgery (Volume and Value) by Type
2.3 Global Biosurgery (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Biosurgery Sales, Consumption, Export, Import by Regions (2017-2023)
Chapter 5 North America Biosurgery Market Analysis
Chapter 6 East Asia Biosurgery Market Analysis
Chapter 7 Europe Biosurgery Market Analysis
Chapter 8 South Asia Biosurgery Market Analysis
Chapter 9 Southeast Asia Biosurgery Market Analysis
Chapter 10 Middle East Biosurgery Market Analysis
Chapter 11 Africa Biosurgery Market Analysis
Chapter 12 Oceania Biosurgery Market Analysis
Chapter 13 South America Biosurgery Market Analysis
Chapter 14 Company Profiles and Key Figures in Biosurgery Business
Chapter 15 Global Biosurgery Market Forecast (2023-2030)
Chapter 16 Conclusions
Research Methodology
About US
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us
Mr. Shah
Coherent Market Insights Pvt Ltd,
533 Airport Boulevard, Suite 400,
Burlingame, CA 94010, United States
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com